{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:27:51Z","timestamp":1718411271134},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.7759\/cureus.62400","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:37:01Z","timestamp":1718404621000},"source":"Crossref","is-referenced-by-count":0,"title":["Liver Disease as a Potential Risk Factor for Colorectal Cancer: A Community Hospital Experience"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Aillaud-De-Uriarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A","family":"Hernandez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hair\u00e9","family":"Manzano-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Marines-Copado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi H","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023, 79:516-37. 10.1016\/j.jhep.2023.03.017","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan WK","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023, 32:197-213. 10.7570\/jomes23052","journal-title":"J Obes Metab Syndr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"\u00c5berg F","year":"2023","unstructured":"\u00c5berg F, Byrne CD, Pirola CJ, M\u00e4nnist\u00f6 V, Sookoian S. alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol. 2023, 78:191-206. 10.1016\/j.jhep.2022.08.030","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2016-134383","article-title":"Non-alcoholic fatty liver disease and colorectal cancer","volume":"93","author":"Mikolasevic I","year":"2017","unstructured":"Mikolasevic I, Orlic L, Stimac D, Hrstic I, Jakopcic I, Milic S. Non-alcoholic fatty liver disease and colorectal cancer. Postgrad Med J. 2017, 93:153-8. 10.1136\/postgradmedj-2016-134383","journal-title":"Postgrad Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker E","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JL, Kasi PM, Wallace MB. Colorectal cancer. Lancet Lond Engl. 2019, 394:1467-80. 10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet Lond Engl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan E","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, et al.. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023, 72:338-44. 10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/M23-0779","article-title":"Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians (Version 2)","volume":"176","author":"Qaseem A","year":"2023","unstructured":"Qaseem A, Harrod CS, Crandall CJ, et al.. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2023, 176:1092-1100. 10.7326\/M23-0779","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12593","article-title":"Colorectal cancer screening starting at age 45 years-ensuring benefits are realized by all","volume":"4","author":"Mehta SJ","year":"2021","unstructured":"Mehta SJ, Morris AM, Kupfer SS. Colorectal cancer screening starting at age 45 years-ensuring benefits are realized by all. JAMA Netw Open. 2021, 4:e2112593. 10.1001\/jamanetworkopen.2021.12593","journal-title":"JAMA Netw Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1617696","article-title":"Association between non-alcoholic fatty liver disease and colorectal cancer","volume":"13","author":"Parizadeh SM","year":"2019","unstructured":"Parizadeh SM, Parizadeh SA, Alizade-Noghani M, et al.. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Rev Gastroenterol Hepatol. 2019, 13:633-41. 10.1080\/17474124.2019.1617696","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118507","article-title":"Nonalcoholic fatty liver disease and colorectal cancer: correlation and missing links","volume":"262","author":"Chakraborty D","year":"2020","unstructured":"Chakraborty D, Wang J. Nonalcoholic fatty liver disease and colorectal cancer: correlation and missing links. Life Sci. 2020, 262:118507. 10.1016\/j.lfs.2020.118507","journal-title":"Life Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1580143","article-title":"The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies","volume":"13","author":"Chen J","year":"2019","unstructured":"Chen J, Bian D, Zang S, et al.. The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies. Expert Rev Gastroenterol Hepatol. 2019, 13:385-95. 10.1080\/17474124.2019.1580143","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02377.x","article-title":"Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia","volume":"270","author":"Stadlmayr A","year":"2011","unstructured":"Stadlmayr A, Aigner E, Steger B, et al.. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med. 2011, 270:41-9. 10.1111\/j.1365-2796.2011.02377.x","journal-title":"J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-014-3157-y","article-title":"Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study","volume":"41","author":"Lin XF","year":"2014","unstructured":"Lin XF, Shi KQ, You J, et al.. Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study. Mol Biol Rep. 2014, 41:2989-97. 10.1007\/s11033-014-3157-y","journal-title":"Mol Biol Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226351","article-title":"The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study","volume":"15","author":"Lee JM","year":"2020","unstructured":"Lee JM, Park YM, Yun JS, et al.. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study. PLoS One. 2020, 15:e0226351. 10.1371\/journal.pone.0226351","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000973","article-title":"The fatty liver index: a simple and accurate predictor of colorectal adenoma in an average-risk population","volume":"61","author":"Ze EY","year":"2018","unstructured":"Ze EY, Kim BJ, Jun DH, Kim JG, Kang H, Lee DY. The fatty liver index: a simple and accurate predictor of colorectal adenoma in an average-risk population. Dis Colon Rectum. 2018, 61:36-42. 10.1097\/DCR.0000000000000973","journal-title":"Dis Colon Rectum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla S","year":"2021","unstructured":"Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken). 2021, 17:365-70. 10.1002\/cld.1061","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.08.003","article-title":"Non-alcoholic fatty liver disease and colorectal cancer: a marker of risk or common causation?","volume":"87","author":"Katsiki N","year":"2018","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease and colorectal cancer: a marker of risk or common causation?. Metabolism. 2018, 87:A10-3. 10.1016\/j.metabol.2018.08.003","journal-title":"Metabolism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262546-liver-disease-as-a-potential-risk-factor-for-colorectal-cancer-a-community-hospital-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:37:04Z","timestamp":1718404624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262546-liver-disease-as-a-potential-risk-factor-for-colorectal-cancer-a-community-hospital-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.62400","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}